Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05350410 · ClinicalTrials.gov registry record · NA

"Healthy Actions and Lifestyles to Avoid Dementia or Hispanos y el ALTo a la Demencia Program"

A NA study of Dementia and Alzheimers Disease, sponsored by Alzheimer's Disease Cooperative Study (ADCS).

Completed
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT05350410 is a NA study of Dementia and Alzheimers Disease that has completed, run by Alzheimer's Disease Cooperative Study (ADCS). The registered enrollment target is 20 participants, below the 7,723-participant average among 199 other Dementia trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05350410, a NA study of Dementia and Alzheimers Disease, has completed, sponsored by Alzheimer's Disease Cooperative Study (ADCS).

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

A Pilot Study for the Healthy Actions and Lifestyles to Avoid Dementia or Hispanos y el ALTo a la Demencia program (HALT-AD). This initial four-months pilot study will focus on at least three educational courses (introduction to dementia and lifestyle risk factors, sleep and diet). It may also include a fourth educational course on social connectivity and loneliness. Completion of this initial pilot study will allow for a round of improvements informed by data from the program, on usability, as well as feedback from participants and citizen advisors. This will allow for an iterative process to build the program to its full content, with feedback to optimize the user experience and ensure the accessibility of the content. The information generated from this study will help inform the development of the second program's prototype, expected to benefit from the initial pilot to become more user-friendly, effective and accessible to the target audience. This pilot study will be a longitudinal study of an inception cohort exposed to the HALT-AD online educational program for a four-month study. It will utilize pre- and post- intervention collection of quantitative and qualitative data to evaluate the program's first prototype.

Interventions

  • BEHAVIORAL HALT-AD

Study Locations (1)

California

  • Alzheimer's Disease Cooperative Study (ADCS) - La Jolla

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2022-04-05
Est. Completion 2022-08-24
Phase NA

What the Registry Record Tells You About NCT05350410

The ClinicalTrials.gov registry entry for NCT05350410 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 7,723-participant average among 199 other Dementia trials with a reported enrollment target (100% lower). The listed sponsor is Alzheimer's Disease Cooperative Study (ADCS), which has 10 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Dementia appearing as the primary indexed condition, and to 1 intervention - of which HALT-AD is the first listed.

NCT05350410 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT05350410 about?

NCT05350410 is a clinical study titled ""Healthy Actions and Lifestyles to Avoid Dementia or Hispanos y el ALTo a la Demencia Program"". A Pilot Study for the Healthy Actions and Lifestyles to Avoid Dementia or Hispanos y el ALTo a la Demencia program (HALT-AD). This initial four-months pilot study will focus on at least three educational courses (introduction to dementia and lifestyle risk factors, sleep and diet). It may also inclu...

What is the current status of trial NCT05350410?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2022-04-05. Estimated completion is 2022-08-24.

What conditions does trial NCT05350410 study?

This clinical trial studies the following conditions: Dementia, Alzheimers Disease, Dementia Prevention.

What interventions are being tested in trial NCT05350410?

The interventions under investigation include: HALT-AD (BEHAVIORAL).

Who is sponsoring clinical trial NCT05350410?

This trial is sponsored by Alzheimer's Disease Cooperative Study (ADCS), which has 10 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05350410 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Dementia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.